These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6322905)

  • 21. Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
    Minsker DH; Bagdon WJ; Robertson RT; Bokelman DL
    J Toxicol Environ Health; 1984; 14(5-6):715-22. PubMed ID: 6097696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
    Burnier M; Biollaz J; Brunner HR; Turini GA; Gavras H
    Am J Cardiol; 1982 Apr; 49(6):1550-1. PubMed ID: 6280484
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations.
    Johnston RT; de Bono DP; Nyman CR
    Int J Cardiol; 1992 Feb; 34(2):213-5. PubMed ID: 1737674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
    Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
    [No Abstract]   [Full Text] [Related]  

  • 25. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
    Lazowski J
    Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML; Kurz KD
    J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
    [No Abstract]   [Full Text] [Related]  

  • 28. Converting enzyme inhibitors in hemodialysis.
    Bazilinski N
    Int J Artif Organs; 1983 Mar; 6(2):62-4. PubMed ID: 6302010
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors and psoriasis.
    Coulter DM; Pillans PI
    N Z Med J; 1993 Sep; 106(963):392-3. PubMed ID: 8396227
    [No Abstract]   [Full Text] [Related]  

  • 30. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention.
    Shemirani H; Pourrmoghaddas M
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):280-5. PubMed ID: 22382219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.
    Webster J; Murchison LE; Robb OJ
    Scott Med J; 1988 Apr; 33(2):247-8. PubMed ID: 2840738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
    Jover B; Dupont M; Casellas D; Mimran A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
    Cooke HM; De Besse A
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat.
    Unger T; Schüll B; Rascher W; Lang RE; Ganten D
    Biochem Pharmacol; 1982 Oct; 31(19):3063-70. PubMed ID: 6293506
    [No Abstract]   [Full Text] [Related]  

  • 37. Captopril.
    Ram CV
    Arch Intern Med; 1982 May; 142(5):914-6. PubMed ID: 6282230
    [No Abstract]   [Full Text] [Related]  

  • 38. Diuretics potentiate the angiotensin converting-enzyme inhibitor-associated acute renal dysfunction.
    Lee HC; Pettinger WA
    Clin Nephrol; 1992 Oct; 38(4):236-7. PubMed ID: 1424316
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibitor treatment of hypertension in infancy and childhood.
    Sigström L; Aurell M; Jodal U
    Scand J Urol Nephrol Suppl; 1984; 79():107-9. PubMed ID: 6089308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
    Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.